In return for the rights to YL201 outside China, MediLink will receive upfront and potential near-term milestone payments ...

MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of ...

If you are wondering whether Roche Holding is still an attractive opportunity after its recent run, or whether that value is already reflected in the price, this article will walk through what the ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in its ...

BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort ...

Roche has removed eight phase 1 and 2 oncology and neurology candidates from its pipeline as part of a set of “trade-offs” intended to “increase the overall portfolio value and speed up development.” ...

Roche has received a dressing-down for omitting important safety information from a cancer drug dosing webpage. A U.K. self-regulatory body concluded Roche brought discredit upon, and reduced ...

S witzerland-based biotechnology giant Roche plans to invest $50 billion in the United States in the next five years. These investments will further strengthen Roche’s U.S. footprint with 13 ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...

Swiss pharmaceuticals company Roche agreed to acquire U.S.-based weight-loss drugmaker Carmot Therapeutics, which develops anti-obesity and diabetes drugs, for $2.7 billion, according to a press ...